Skip to content
MedsAcross

Medicine

Dextroamphetamine 5 mg extended-release capsule

Available on requestPrescription onlyUS FDAControlled, schedule CIIGeneric name

Dextroamphetamine 5 mg extended-release capsule is a generic prescription medicine for oral use, made by 3 labelers, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.

Availability

Available on request

Export supply from India to licensed buyers

Typical lead time

On request

Counted from payment and complete documents

Shipping

Ambient

Store at controlled room temperature between 20° to 25°C (68° to 77°F).

Key facts

Active ingredient (INN)
Dextroamphetamine
Brand
Sold under the generic name
Strength
5 mg
Dosage form
Extended-release capsule
Route
Oral
Packs
90 capsules, 100 capsules
Manufacturers
Actavis PharmaAmneal Pharmaceuticals of New YorkSpecGx
Origin register
US FDA, United States
Storage
Store at controlled room temperature between 20° to 25°C (68° to 77°F).
Cold chain
Not required on record
Prescription status
Prescription only
Controlled substance
Schedule CII
ATC code
N06BA02 Dextroamphetamine
HS code (indicative)
3004.90Indicative only. Your customs broker confirms the final tariff code.
Marketing category
marketed
Marketed since
2 August 1976
Identifiers
RxCUI 884520, 884532, 884535DailyMed set ID 9e92ccc3-d81c-461d-a19f-7e9b582be357, 2ec5c30f-4eb8-48a5-83c4-236450413464, 69c40af8-3710-46bf-bd3d-137fe5eea23eNDC 45963-303, 0115-9927, 0406-8960Application ANDA203901, NDA017078, ANDA076353

Record updated 12 November 2026

Documents available

Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.

No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.

Packs

Packs from every labeler of this generic presentation.

PackCodeLabelerMarketed since
90 capsule, extended release in 1 bottle45963-303-09Actavis Pharma19 June 2014
90 capsule, extended release in 1 bottle0115-9927-10Amneal Pharmaceuticals of New York2 August 1976
100 capsule, extended release in 1 bottle0406-8960-01SpecGx6 May 2003

Status by register

Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.

RegisterStatusSource
US FDAListed, marketedSource record for this pageChecked 12 November 2026
US FDAFirst approved 2 August 1976Drugs@FDA
EU (EMA)Not recorded—
India (CDSCO)Not yet confirmed against CDSCO approval lists—
United StatesRegisteredUS FDA (NDC directory, openFDA)Checked 12 November 2026

Import route

Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.

Import guides are available for 25 countries. Pick one to see its route summary.

BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides

Alternatives

Other makers and brands of Dextroamphetamine 5 mg extended-release capsule.

Compare 1

Other strengths and forms of Dextroamphetamine

Clinical summary

Dextroamphetamine is a central nervous system stimulant indicated as an integral part of a total treatment program that typically includes other measures (psychological, educational, social) for patients (ages 6 years to 16 years) with this syndrome. MedsAcross supplies Dextroamphetamine for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.

Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review

Read about Dextroamphetamine

For healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.

Data sources

Need Dextroamphetamine 5 mg extended-release capsule for your hospital or patient?

Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.